Roger Adsett

Roger Adsett (senior executive) discloses dealings in 2 companies, chiefly INSMED Inc and Definium Therapeutics, Inc. Between 12 May 2021 and 10 August 2026, the trades on record add up to 41 filings.

Sales make up the whole of the open-market record (26 sales, €46.7M). Outside the open market, there are 11 share grants and 4 option exercises. In 2026 alone, the filings show no purchases and 8 sales.

The record was last updated on 12 August 2026 with an option exercise (€973k) in INSMED Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.